Related references
Note: Only part of the references are listed.Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide)
R. T. Morris et al.
ANNALS OF ONCOLOGY (2014)
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study
M. Koebel et al.
BRITISH JOURNAL OF CANCER (2014)
Origin and molecular pathogenesis of ovarian high-grade serous carcinoma
R. J. Kurman
ANNALS OF ONCOLOGY (2013)
PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer
R. Wendel Naumann et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response
Yu-Li Chen et al.
MOLECULAR ONCOLOGY (2012)
DNA ploidy, nuclear size, proliferation index and DNA-hypomethylation in ovarian cancer
Alain G. Zeimet et al.
GYNECOLOGIC ONCOLOGY (2011)
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-Shifting the paradigm
Robert J. Kurman et al.
HUMAN PATHOLOGY (2011)
Researchers find a new cancer gene and a possible link between ovarian cancer and endometriosis
[Anonymous]
WOMENS HEALTH (2010)
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Kimberly C. Wiegand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Functional characterization of human proton-coupled folate transporter/heme carrier protein 1 heterologously expressed in mammalian cells as a folate transporter
Yasuhiro Nakai et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Clinical relevance of E2F family members in ovarian cancer - An evaluation in a training set of 77 patients
Daniel Reimer et al.
CLINICAL CANCER RESEARCH (2007)
Cancer statistics, 2007
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
The molecular identity and characterization of a Proton-Coupled Folate Transporter-PCFT; biological ramifications and impact on the activity of pemetrexed
Rongbao Zhao et al.
CANCER AND METASTASIS REVIEWS (2007)
The role of folate receptor α in cancer development, progression and treatment:: Cause, consequence or innocent bystander?
Linda E. Kelemen
INTERNATIONAL JOURNAL OF CANCER (2006)
Multivitamin and alcohol intake and folate receptor α expression in ovarian cancer
LE Kelemen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay
N Parker et al.
ANALYTICAL BIOCHEMISTRY (2005)
Reduced folate carrier mutations are not the mechanism underlying methotrexate resistance in childhood acute lymphoblastic leukemia
Y Kaufman et al.
CANCER (2004)
DNA hypomethylation and ovarian cancer biology
M Widschwendter et al.
CANCER RESEARCH (2004)
Ovarian tumorigenesis - A proposed model based on morphological and molecular genetic analysis
IM Shih et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Expression of folate receptors and heterogeneous nuclear ribonucleoprotein E1 in women with human papillomavirus mediated transformation of cervical tissue to cancer
MR Pillai et al.
JOURNAL OF CLINICAL PATHOLOGY (2003)
Chromosomal instability and tumors promoted by DNA hypomethylation
A Eden et al.
SCIENCE (2003)
Comprehensive analysis of CpG islands in human chromosomes 21 and 22
D Takai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Analyses of MYC, ERBB2, and CCND1 genes in benign and malignant thyroid follicular cell tumors by real-time polymerase chain reaction
I Bièche et al.
THYROID (2001)
Share Paper
